2-(chloromethyl)-4-methyl-4,5-dihydro-1,3-oxazole 、 (3S)-5-(6-chloro-9H-β-carbolin-8-ylcarbamoyl)-2,2-dimethyl-morpholine-4-carboxylic acid trifluoroacetate 在
N,N-二异丙基乙胺 、 potassium iodide 作用下,
以
N,N-二甲基甲酰胺 为溶剂,
反应 12.0h,
生成
(3S)-N-(6-chloro-9H-β-carbolin-8-yl)-6,6-dimethyl-4-[((4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl)methyl]morpholine-3-carboxamide 、
(3S)-N-(6-chloro-9H-β-carbolin-8-yl)-6,6-dimethyl-4-[((4S)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl)methyl]morpholine-3-carboxamide